文献速递心脏核医学

奥地利、德国和瑞士的SPECT与PET心肌灌注显像:2021年首次联合调查结果

SPECT and PET myocardial perfusion imaging in Austria, Germany, and Switzerland results of the first joint survey of 2021.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2023-07-15

该调查于2022年向奥地利、德国和瑞士的核医学中心发放问卷,分析2021年SPECT和PET心肌灌注显像及心脏淀粉样变显像的使用情况。结果显示三国间存在显著差异:瑞士PET心肌灌注显像使用广泛且设备领先,奥地利和德国PET心肌灌注显像数量接近于零;尽管操作流程不同,整体心肌灌注显像水平较高。

要点

  • 奥地利和德国PET心肌灌注显像数量接近于零,未纳入分析;瑞士PET心肌灌注显像使用广泛。
  • 门诊心脏科医生是主要转诊来源(56-71%),负荷试验多采用药物负荷(58-92%)。
  • 奥地利和瑞士以1天方案为主(58-97%),与德国不同;SPECT心肌灌注显像衰减校正比例瑞士最高(84%)。

核心结论

  • 2021年首次联合调查显示三国间存在显著差异,瑞士因广泛使用PET心肌灌注显像而表现突出,设备方面瑞士也领先,其次为奥地利和德国。
  • 尽管操作流程存在差异,结果揭示心肌灌注显像整体水平较高。

研究设计与样本

  • 2022年向奥地利、德国和瑞士从事核医学的中心发放问卷,调查2021年SPECT和PET心肌灌注显像及心脏淀粉样变显像的使用情况。
  • 分析了奥地利14个中心(10,710例SPECT)、德国218个中心(133,047例SPECT)和瑞士16个中心(11,601例心肌灌注显像,其中SPECT 6,879例、PET 4,722例)的数据。

主要发现

  • 奥地利和德国PET心肌灌注显像数量接近于零,未纳入分析。
  • 奥地利和德国2015至2021年官方心肌灌注显像数量显示,奥地利在2020至2021年疫情期间下降约40%,而德国增加9%。
  • 门诊心脏科医生是主要转诊群体(56-71%),负荷试验多采用药物负荷(58-92%)。
  • 与德国不同,奥地利和瑞士以1天方案为主(58-97%)。
  • 主要相机系统:奥地利和瑞士为SPECT-CT(57-79%),德国为多探头系统(58%)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This paper presents the results of the first joint survey on the use of SPECT and PET myocardial perfusion imaging (MPI) and cardiac amyloidosis imaging in Austria, Germany, and Switzerland of the year 2021. METHODS: A questionnaire was sent in 2022 to centres practicing nuclear medicine. RESULTS: Data from 14 Austrian (10,710 SPECT), 218 German (133,047 SPECT), and 16 Swiss centres (11,601 MPI (6,879 SPECT, 4722 PET)) were analysed. In Austria and Germany, the PET MPI numbers were close to zero and not considered. Official MPS numbers from 2015 to 2021 from Austria and Germany revealed a decline in Austria by about 40% in the pandemic years 2020 to 2021, but an increase in Germany by 9%. Ambulatory care cardiologists represented the major referral group (56-71%). Mostly, stress tests were performed pharmacologically (58-92%). Contrary to Germany, a 1-day protocol was predominant (58-97%) in Austria and Switzerland. The leading camera systems were SPECT-CT in Austria and Switzerland (57-79%) and multi-head systems in Germany (58%). Switzerland had the highest proportion of SPECT MPI with attenuation correction (84%), followed by Austria (43%), and Germany (33%). Electrocardiogram-gated SPECT MPI showed an overall high penetration of 87-99%. Scoring was most frequently applied in Germany (72%), followed by Austria (64%), and Switzerland (60%). Related to the population, the number of cardiac amyloidosis imaging was highest in Austria, followed by Switzerland and Germany. CONCLUSIONS: This first joint survey of 2021 shows considerable differences among the countries. The Swiss situation is outstanding due to the wide use of PET MPI. In terms of camera equipment, Switzerland is also leading, followed by Austria and Germany. Despite the differences in procedural issues, the results reveal an overall high standard of MPI imaging.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Lindner O, Hacker M, Burchert W, et al. SPECT and PET myocardial perfusion imaging in Austria, Germany, and Switzerland results of the first joint survey of 2021. Eur J Nucl Med Mol Imaging. 2023. PMID: 37452873. doi:10.1007/s00259-023-06336-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。